Navigation Links
Sparking Growth In Ontario's Biopharmaceutical Industry
Date:2/4/2008

Support For Cutting-Edge Health Research Will Create Jobs, Attract

Investment

TORONTO, Feb. 4 /PRNewswire/ - The Ontario government is providing $150 million through the Next Generation Jobs Fund to encourage research-based pharmaceutical companies to invest in Ontario, Minister of Research and Innovation John Wilkinson has announced.

"Attracting these investments will create good-paying jobs that support the discovery of new medical treatments for diseases that affect us all," said Wilkinson. "Supporting this research will strengthen Ontario's economy and create a higher quality of life for Ontario families."

The biopharmaceutical industry:

- Employs over 9,000 Ontarians in high-value jobs, such as researchers

and scientists

- Invested more than $550-million in Ontario in 2006 to enable the

discovery of life-saving therapies, such as antibiotics, new vaccines

and more effective cancer treatments

- Makes up thirty-one of Canada's top 100 corporate R&D investors.

The $150 million will create jobs in the biopharmaceutical research community by enabling companies to apply for grants, loans, forgivable interest loans and funds for building infrastructure, research and training.

"Our government's $150 million investment is focused on increasing the amount of health research and advanced manufacturing activity that is happening right here in Ontario," said Minister of Economic Development and Trade Sandra Pupatello. "The significant investments that biopharmaceutical companies make in health research are essential to the growth and success of our emerging biotechnology industry, and other sectors that are important to Ontario's economy."

The $1.15-billion Next Generation Jobs Fund supports job creation in areas where Ontario has a strong competitive advantage and is designed to build and strengthen industry, create jobs and make Ontario globally competitive in key sectors.

"Today's announcement sends a signal not only to the domestic biopharmaceutical industry, but also to our global community that Ontario values this sector and its potential for growth," said Ronnie Miller, Chairman of Rx&D and President & CEO Hoffmann-La Roche Limited. "By working together with the Ontario government, our community is setting a course for the future that will help ensure we can continue to invest today in the medical discoveries of tomorrow, retain our brightest minds here at home and ultimately, ensure patients benefit from access to these new medicines and vaccines."

"Ontario enjoys a vibrant, world-class health research sector," said Janet Rossant, Chief of Research, The Hospital for Sick Children. "Incentives like this new biopharmaceutical investment program will ensure that partnerships between industry and researchers in Ontario continue to build a strong knowledge-based economy that will create jobs and improve the health of our population."

The $150-million biopharmaceutical investment program is just one of the ways the Ontario government is strengthening the economy and supporting Ontario families. Other initiatives include:

- Encouraging strong job creation, with over 417,000 net new jobs since

October 2003

- Launching the $160 million Ideas-to-Market strategy that supports

emerging companies

- Helping Ontario's brightest researchers move their new ideas from

labs to the global marketplace by investing $527 million over five

years in the Ontario Research Fund

- Establishing a six-year, $500-million Advanced Manufacturing

Investment Strategy to help manufacturers invest in innovative new

technologies

- Providing a 21 per cent Capital Tax rate cut for all businesses

retroactive to January 1, 2007, on the way to full elimination in

2010

- Eliminating the Capital Tax on January 1, 2008 for corporations

primarily engaged in manufacturing and resource activities and

- Announcing in the 2007 Fall Economic Statement an additional

$50 million in strategic investment to further strengthen Ontario's

environment for scientific research that will lead to new

discoveries, higher quality of life and new jobs.


'/>"/>
SOURCE Ontario Ministry of Economic Development and Trade
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
2. Pathway Medical Technologies Adds Joe Rafferty as VP, Sales, and Moves To Larger Facility to Accommodate Rapid Growth
3. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
4. STALLERGENES : Strong Business Growth: +17% and Earnings Per Share up 30%
5. Monogram Biosciences to Present at the ThinkEquity Partners Fifth Annual Growth Conference
6. Favrille to Present at AG Edwards Emerging Growth Conference and Wall Street Analyst Forum
7. Sigma-Aldrich Expansion in Republic of China to Support SAFC Growth
8. Bionovo to Present at A.G. Edwards 2nd Annual Emerging Growth Conference 2007
9. Kensey Nash to Present at the Sidoti Sixth Annual West Coast Emerging Growth Institutional Investor Forum Conference
10. Medarex to Present at the A.G. Edwards 2nd Annual Emerging Growth Conference
11. ADVENTRX Pharmaceuticals to Present at the ThinkEquity Partners Fifth Annual Growth Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/2/2016)... , May 2, 2016 ... that its technology partner Mannin Research Inc. will be ... (ARVO), which takes place from May 1-5, 2016 in ... will be meeting with its vendors and research partners. ... business development goals and other collaborative opportunities for the ...
(Date:5/2/2016)... ... May 02, 2016 , ... StarNet Communications Corp, ( http://www.starnet.com/ ... addition of three Secure Remote Desktop modules to its flagship X-Win32 PC X server. ... and Unix servers to the user’s PC over encrypted SSH. , Traditionally, users of ...
(Date:4/29/2016)... , ... April 30, 2016 , ... The MIT bioLogic ... design, the bioLogic team explored how bacterial properties can be applied to fabric and ... Natto bacteria, which move in response to humidity change. The team harvested Natto cells ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... used in spinal surgical procedures, today announced the completion of a significant transaction ... for current and future customers and partners. Kohlberg & Company, L.L.C. (“Kohlberg”), ...
Breaking Biology Technology:
(Date:3/22/2016)... , March 22, 2016 ... research report "Electronic Sensors Market for Consumer Industry by ... & Others), Application (Communication & IT, Entertainment, ... - Global Forecast to 2022", published by ... is expected to reach USD 26.76 Billion ...
(Date:3/17/2016)... , March 17, 2016 ABI ... intelligence, forecasts the global biometrics market will reach ... impressive 118% increase from 2015. Consumer electronics, particularly ... embedded fingerprint sensors anticipated to reach two billion ... Dimitrios Pavlakis , Research Analyst at ...
(Date:3/14/2016)... March 14, 2016 http://www.apimages.com ... --> - Renvoi : image disponible via ... --> --> DERMALOG, le ... de nouveaux lecteurs d,empreintes digitales pour l,enregistrement des ... sera utilisé pour produire des cartes d,identité aux ...
Breaking Biology News(10 mins):